Chitosan-based drug delivery systems for skin atopic dermatitis: recent advancements and patent trends.

ABSTRACT: Atopic dermatitis (AD) is a complex, relapsing inflammatory skin disease with a considerable social and economic burden globally. AD is primarily characterized by its chronic pattern and it can have important modifications in the quality of life of the patients and caretakers. One of the fastest-growing topics in translational medicine today is the exploration of new or repurposed functional biomaterials into drug delivery therapeutic applications. This area has gained a considerable amount of research which produced many innovative drug delivery systems for inflammatory skin diseases like AD. Chitosan, a polysaccharide, has attracted attention as a functional biopolymer for diverse applications, especially in pharmaceutics and medicine, and has been considered a promising candidate for AD

SUBMITTER: Chuah LH 

PROVIDER: S-EPMC9937521 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature